A vs INVA: fair value comparison
Agilent Technologies, Inc. and Innoviva, Inc. · Updated 2026-09-07
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, A currently sits closer to the top of our discount ranking. INVA carries the stronger quality grade.
| A | INVA | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $150.86 | $20.77 |
| 12-month range | $114.52–$150.10 | $18.11–$23.41 |
| Sector rank | #59 of 113 Healthcare | #60 of 113 Healthcare |
| Quality grade | C | B |
| Leverage | Moderate | Low |
| Margin trend | Contracting | — |
| Revenue growth | Declining | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Downtrend |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: A fair value analysis · INVA fair value analysis